Found: 67
Select item for more details and to access through your institution.
Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 1, p. 191, doi. 10.1007/s00432-021-03668-6
- By:
- Publication type:
- Article
The management of gastrointestinal infections caused by cytomegalovirus.
- Published in:
- 2003
- By:
- Publication type:
- commentary
Elranatamab in Japanese patients with relapsed/refractory multiple myeloma: results from MagnetisMM-2 and MagnetisMM-3.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 9, p. 991, doi. 10.1093/jjco/hyae068
- By:
- Publication type:
- Article
Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 12, p. 1446, doi. 10.1093/jjco/hyac137
- By:
- Publication type:
- Article
Immunomodulatory drugs in the treatment of multiple myeloma.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 8, p. 695, doi. 10.1093/jjco/hyz083
- By:
- Publication type:
- Article
Therapeutic antibodies for multiple myeloma.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 11, p. 957, doi. 10.1093/jjco/hyy133
- By:
- Publication type:
- Article
Proteasome inhibitors for multiple myeloma.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 9, p. 785, doi. 10.1093/jjco/hyy108
- By:
- Publication type:
- Article
Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01909-7
- By:
- Publication type:
- Article
Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Decrease of B-type natriuretic peptide to less than 200 pg/mL predicts longer survival in cardiac immunoglobulin light chain amyloidosis.
- Published in:
- International Journal of Hematology, 2015, v. 102, n. 2, p. 200, doi. 10.1007/s12185-015-1814-0
- By:
- Publication type:
- Article
Autologous stem cell transplantation for AL amyloidosis: adjustment of melphalan dose by factors including BNP.
- Published in:
- International Journal of Hematology, 2014, v. 100, n. 6, p. 554, doi. 10.1007/s12185-014-1680-1
- By:
- Publication type:
- Article
Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group.
- Published in:
- International Journal of Hematology, 2014, v. 100, n. 3, p. 281, doi. 10.1007/s12185-014-1629-4
- By:
- Publication type:
- Article
Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.
- Published in:
- International Journal of Hematology, 2012, v. 96, n. 6, p. 748, doi. 10.1007/s12185-012-1210-y
- By:
- Publication type:
- Article
Reduced-intensity conditioning allogeneic stem cell transplantation for multiple myeloma: results from the Japan Myeloma Study Group.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Quantification of BK polyoma viruria in Japanese children and adults with hemorrhagic cystitis complicating stem cell transplantation.
- Published in:
- Journal of Medical Virology, 2008, v. 80, n. 12, p. 2108, doi. 10.1002/jmv.21328
- By:
- Publication type:
- Article
Quantification of adenovirus species B and C viremia by real‐time PCR in adults and children undergoing stem cell transplantation.
- Published in:
- Journal of Medical Virology, 2007, v. 79, n. 3, p. 278, doi. 10.1002/jmv.20796
- By:
- Publication type:
- Article
Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database.
- Published in:
- PLoS ONE, 2023, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0283931
- By:
- Publication type:
- Article
Development of Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin Changes Syndrome after Conversion from Plasmacytoma of Bone to Multiple Myeloma.
- Published in:
- Internal Medicine, 2023, v. 62, n. 3, p. 475, doi. 10.2169/internalmedicine.9101-21
- By:
- Publication type:
- Article
A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 5, p. 745, doi. 10.1111/bjh.13900
- By:
- Publication type:
- Article
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 11, p. 2142, doi. 10.1007/s10147-021-01991-z
- By:
- Publication type:
- Article
Interferon-α/≳ and Anti-Fibroblast Growth Factor Receptor 1 Monoclonal Antibody Suppress Hepatic Cancer Cells In Vitro and In Vivo.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0019618
- By:
- Publication type:
- Article
Prognostic impact of 1q abnormality on outcomes in patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone in a real-world clinical setting.
- Published in:
- 2024
- By:
- Publication type:
- Letter
A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 475, doi. 10.1007/s00277-023-05428-7
- By:
- Publication type:
- Article
Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 12, p. 3489, doi. 10.1007/s00277-023-05432-x
- By:
- Publication type:
- Article
Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 6, p. 1477, doi. 10.1007/s00277-023-05218-1
- By:
- Publication type:
- Article
Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 12, p. 2989, doi. 10.1007/s00277-021-04634-5
- By:
- Publication type:
- Article
Continuous lenalidomide treatment after bortezomib-melphalan-prednisolone therapy for newly diagnosed multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Heat stress activates ER stress signals which suppress the heat shock response, an effect occurring preferentially in the cortex in rats.
- Published in:
- Molecular Biology Reports, 2012, v. 39, n. 4, p. 3987, doi. 10.1007/s11033-011-1179-2
- By:
- Publication type:
- Article
The efficacy and safety of modified bortezomib‐lenalidomide‐dexamethasone in transplant‐eligible patients with newly diagnosed multiple myeloma.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 2, p. 110, doi. 10.1111/ejh.13349
- By:
- Publication type:
- Article
Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma.
- Published in:
- European Journal of Haematology, 2007, v. 79, n. 3, p. 234, doi. 10.1111/j.1600-0609.2007.00908.x
- By:
- Publication type:
- Article
Occurrence of the African subgroup (Ia) of BK polyomavirus in younger Japanese children.
- Published in:
- Microbiology & Immunology, 2009, v. 53, n. 6, p. 319, doi. 10.1111/j.1348-0421.2009.00129.x
- By:
- Publication type:
- Article
Monoclonal antibodies as effective therapeutic agents for solid tumors.
- Published in:
- Cancer Science, 2004, v. 95, n. 8, p. 621, doi. 10.1111/j.1349-7006.2004.tb03319.x
- By:
- Publication type:
- Article
Human Tumor Growth Suppression by Apoptosis Induced with Anti-ErbB-2 Chimeric Monoclonal Antibody.
- Published in:
- Cancer Science, 1998, v. 89, n. 5, p. 562, doi. 10.1111/j.1349-7006.1998.tb03298.x
- By:
- Publication type:
- Article
Establishment and Characterization of Mouse-Human Chimeric Monoclonal Antibody to erbB-2 Product.
- Published in:
- Cancer Science, 1994, v. 85, n. 2, p. 172, doi. 10.1111/j.1349-7006.1994.tb02079.x
- By:
- Publication type:
- Article
The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome--expansion of SIPS to the territory of Castlemans disease.
- Published in:
- Rheumatology, 2009, v. 48, n. 7, p. 860, doi. 10.1093/rheumatology/kep098
- By:
- Publication type:
- Article
Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e360, doi. 10.1016/j.clml.2023.06.011
- By:
- Publication type:
- Article
Efficacy of intensive salvage regimen (VTD-PACE and DCEP regimen) in the era of novel agents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e273, doi. 10.1016/j.clml.2019.09.451
- By:
- Publication type:
- Article
Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: A multicenter retrospective comparative analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e214, doi. 10.1016/j.clml.2019.09.356
- By:
- Publication type:
- Article
Feasibility study to establish diagnostic biomarkers for relapsed refractory multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e84, doi. 10.1016/j.clml.2019.09.134
- By:
- Publication type:
- Article
Mucins and Immune Reactions to Mucins in Ulcerative Colitis.
- Published in:
- Digestion, 2001, v. 63, p. 28, doi. 10.1159/000051907
- By:
- Publication type:
- Article
MUC1 Mucin Core Protein Binds to the Domain 1 of ICAM-1.
- Published in:
- Digestion, 2001, v. 63, p. 87, doi. 10.1159/000051917
- By:
- Publication type:
- Article
Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 91, doi. 10.1007/s12185-024-03770-8
- By:
- Publication type:
- Article
A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 443, doi. 10.1007/s12185-023-03647-2
- By:
- Publication type:
- Article
Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myeloma.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 5, p. 729, doi. 10.1007/s12185-023-03538-6
- By:
- Publication type:
- Article
MEdical Database AnaLysIS of Japanese multiple myeloma patienTs with apheresis #2 (MEDALIST-2): the impact of plerixafor use on costs and healthcare resources during mobilization and stem cell transplantation.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 411, doi. 10.1007/s12185-022-03356-2
- By:
- Publication type:
- Article
Medical database analysis of japanese multiple myeloma patients with planned stem cell transplantation (MEDALIST) – a focus on healthcare resource utilization and cost.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 2, p. 271, doi. 10.1007/s12185-020-03022-5
- By:
- Publication type:
- Article
Bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma patients: a multicenter retrospective comparative analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Final results of a phase I study of carfilzomib, lenalidomide, and dexamethasone for heavily pretreated multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Red blood cell distribution width is a simple and novel biomarker for survival in light-chain amyloidosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-1. Multiple myeloma (MM).
- Published in:
- 2019
- By:
- Publication type:
- journal article